Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: A pilot study in Iran

Substance Use and Misuse

Volumn 43, Issue 3-4, 2008, Pages 513-520

  Nakhaee, Nouzar ^a,c   Divsalar, Kouros ^a   Meimandi, Manzume Shamsi ^b   Dabiri, Shahriar ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

"Substance abuse"; Detection; Epidemiology; Iran; Male; Opioid related disorders; Urine

Indexed keywords

CODEINE; DIAMORPHINE; DRUG METABOLITE; MORPHINE; OPIATE;

ADULT; ARTICLE; CLINICAL LABORATORY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SCREENING; DRUG URINE LEVEL; DRUG USE; HUMAN; IMMUNOASSAY; IRAN; MALE; MEN'S HEALTH; PILOT STUDY; POPULATION; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; THIN LAYER CHROMATOGRAPHY; URINALYSIS;

ADOLESCENT; ADULT; ANONYMOUS TESTING; HUMANS; IRAN; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PILOT PROJECTS; PREVALENCE;

EID: 41349120545     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080701772348     Document Type: Article

References (23)

1. Cone, E. J. (1997). New developments in biological measures of drug prevalence. NIDA Research Monographs 167:108-129.
2. Cook, R. F., Bernstein, A. D., Andrews, C. M. (1997). Assessing drug use in the workplace: A comparison of self-report, urinalysis, and hair analysis. NIDA Research Monographs 167:247-272.
3. Dixon, W. H. (1972). Narcotics legeslation and Islamin Egypt. Bulletin on Narcotics 24:11-18.
4. Fendrich, M., Johnson, T. P., Wislar, J. S., Hubbell, A., Spiehler, V. (2004). The utility of drug testing in epidemiological research: Results from a general population survey. Addiction 99:197-208.
5. Ghaffari-Nejad, A. R., Pouya, F. (2002). Prevalence of nicotine and opium dependence among psychiatric in-patients in Kerman, southwestern Iran. Iranian Journal of Medical Sciences 27(4):161-165.
6. Ghanizadeh, A. (2001). Shiraz University students' attitude towards drugs: An exploratory study. Eastern Mediterranean Health Journal 7(3):452-460.
7. Jenkins, R. (2001). Making psychiatric epidemiology useful: The contribution of epidemiology to government policy. Acta Psychiatrica Scandinavica 103:2-14.
8. Kapur, B. M. (1993). Drug-testing methods and clinical interpretations of test results. Bulletin on Narcotics 45(2):115-154.
9. Kraus, L., Augustin, R., Frischer, M., Kummler, P., Uhl, A., Weissing, L. (2003). Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 98:471-485.
10. Levine, B., Smialek, J. E. (1998). Considerations in the interpretation of urine analyses in suspected opiate intoxications. Journal of Forensic Sciences 43(2):388-389.
11. Makkai, T. (2001). Patterns of recent drug use among a sample of Australian detainees. Addiction 96(12):1799-1808.
12. Marquet, P., Delpla, P. A., Kerguelen, S., Bremond, J., Facy, F., Garnier, M., et al. (1998). Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: A collaborative study. Journal of Forensic Sciences 43(4):806-811.
13. Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Archives of Iranian Medicine 5:184-190.
14. Morgan, J. (1984). Problems of urine screening. Journal of Psychoactive Drugs 16(4):305-317.
15. Nissaramanesh, B., Trace, M., Roberts, M. (2005). The rise of harm reduction in the Islamic Republic of Iran. Beckley Park, UK: The Beckley Foundation Drug Policy Programme (BFDPP).
16. Rajabizadeh, G., Ramezani, M. A., Shakibi, M. R. (2004). Prevalence of opium addiction in Iranian drivers 2001-2003. Journal of Medical Sciences (Pakistan) 4(3):210-213.
17. Razzaghi, E., Rahimi, A., Hosseini, M., Chatterjee, A. (1999). Rapid situation assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, I.R. of Iran and United Nations International Drug Control program, Tehran.
18. United Nations Office on Drugs and Crime. (2004). World drug report 2004. Geneva: Author.
19. Vandevenne, M., Vandenbussche, H., Verstraete, A. (2000). Detection time of drugs of abuse in urine. Acta Clinica Belgica 55(6):323-333.
20. Warner, E. A., Walker, R. M., Friedmann, P. D. (2003). Should informed consent be required for laboratory testing for drugs of abuse in medical settings? American Journal of Medicine 115:54-58.
21. World Health Organization. (2000). Guide to drug abuse epidemiology. Geneva: Author.
22. Wu, A. H., Bristol, B., Sexton, K., Cassella-McLane, G., Holtman, V., Hill, D. W. (1999). Adulteration of urine by "urine luck." Clinical Chemistry 45(7):1051-1057.
23. Ziaaddini, H., Ziaaddini, M. R. (2005). The household survey of drug abuse in Kerman, Iran. Journal of Applied Sciences 5(2):380-382.